Locations:
SearchAdvertisement
Profile of six ongoing studies aiming to overcome anatomic hurdles
Large analysis offers most definitive insights yet into ‘diabetes paradox’
Celecoxib has least impact, followed by naproxen and ibuprofen
ACCELERATE substudy shows no benefit of evacetrapib in patients with diabetes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Post hoc analysis suggests more heart failure patients might benefit
Progress in quest for autoimmune mechanisms behind idiopathic dilated CM
Findings call for revisiting readmission prevention strategies
Extension of the gut microbial pathway has therapeutic implications for obesity, diabetes
Incremental prognostic value demonstrated for the first time
Findings can guide decisions between LVAD and optimal medical care
Advertisement
Advertisement